Quarterly Results

SYNCOM HEALTHCARE LTD.

NSE : SYNCOMBSE : 533157ISIN CODE : INE602K01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.120 (0 %)
PREV CLOSE ( ) 4.12
OPEN PRICE ( ) 3.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 163615
TODAY'S LOW / HIGH ( )3.95 4.33
52 WK LOW / HIGH ( )3.95 4.33
NSE4.200 (0 %)
PREV CLOSE( ) 4.20
OPEN PRICE ( ) 4.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4.20 (50)
VOLUME 332739
TODAY'S LOW / HIGH( ) 3.95 4.30
52 WK LOW / HIGH ( )3.95 4.3
Quarters
Select year  
( in Million)
Particulars
Jun 2021
Mar 2021
Dec 2020
Sep 2020
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
3.52
4.55
4.53
6.05
Total Expenditure
11.34
13.43
12.91
11.69
PBIDT (Excl OI)
-7.82
-8.88
-8.38
-5.64
Other Income
0.59
2.72
0.21
0.78
Operating Profit
-7.23
-6.16
-8.17
-4.87
Interest
0.02
0.13
0.04
0.03
Exceptional Items
NA
NA
NA
NA
PBDT
-7.25
-6.29
-8.21
-4.9
Depreciation
3.81
4.39
4.47
5.86
Profit Before Tax
-11.06
-10.68
-12.68
-10.76
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-11.06
-10.68
-12.68
-10.76
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-11.06
-10.68
-12.68
-10.76
Equity Capital
400
400
400
400
Face Value (IN RS)
10
10
10
10
Reserves
-584.35
-573.25
-562.58
-549.9
Calculated EPS
-0.27
-0.26
-0.31
-0.26
Calculated EPS (Annualised)
-1.10
-1.06
-1.26
-1.07
No of Public Share Holdings
39949900
39949900
39949800
39949800
% of Public Share Holdings
99.87
99.87
99.87
99.87
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-222.15
-195.16
-184.98
-93.22
PBIDTM%
-205.39
-135.38
-180.35
-80.49
PBDTM%
-205.96
-138.24
-181.23
-80.99
PBTM%
-314.20
-234.72
-279.91
-177.85
PATM%
-314.20
-234.72
-279.91
-177.85
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.